Aegon Ltd. (AEG) 10-Year Financial Performance & Capital Metrics

AEG • • Insurance & Managed Care

Financial ServicesDiversified InsuranceRetirement & Wealth SolutionsRetirement & Annuity Specialists

AboutAegon Ltd. provides insurance, pensions, and asset management services in the Americas, the Netherlands, and the United Kingdom. The company offers life, accident, and health insurance; savings, pension, annuities, and mutual funds; property and casualty insurance; retirement plans and individual retirement accounts; voluntary employee benefits; and stable value solutions. It also provides debt securities; mortgage loans; derivatives; reinsurance assets; other loans; money market and short-term investments; credit risk management; disability services; and digital banking solutions. Aegon N.V. was founded in 1983 and is headquartered in The Hague, the Netherlands.Show more

Revenue $19.52B +50.4%
Combined Ratio 96.63% -38.7%
Net Income $688M +484.4%
Return on Equity 7.34% +584.4%
Medical Cost Ratio 0% -100.0%
Operating Margin 3.37% -96.5%
Net Margin 3.52% +355.6%
ROA 0.22% +529.9%
Equity / Assets 2.84% -9.0%
Book Value per Share 4.63 -7.0%
Tangible BV/Share 4.35 -7.8%
Debt/Equity 0.54 +2.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9
✓Healthy dividend yield of 3.4%

✗Weaknesses

✗Weak 3Y average ROE of 1.0%
✗Profits declining 11.1% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-7.79%

5Y-20.41%

3Y-25.13%

TTM-10.94%

Profit (Net Income) CAGR

10Y-5.3%

5Y-11.1%

3Y-29.7%

TTM248.42%

EPS CAGR

10Y-4.79%

5Y-12.94%

3Y-14.5%

TTM236.33%

ROCE

10Y Avg2.37%

5Y Avg4.45%

3Y Avg1.33%

Latest0.21%

Peer Comparison

Retirement & Annuity Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AEGAegon Ltd.	11.54B	7.67	25.57	50.4%	4.24%	13.27%	6.16%	0.54
PFGPrincipal Financial Group, Inc.	19.56B	89.02	13.33	18.02%	7.53%	9.61%	23.18%	0.36
EQHEquitable Holdings, Inc.	13.42B	46.82	12.39	18.13%	-5.8%	-35.73%	11.07%	1.90
SLFSun Life Financial Inc.	34.02B	61.43	11.66	-5.15%	8.54%	11.91%	7.02%	0.65
BNTBrookfield Wealth Solutions Ltd.	2.84B	47.38	6.72	106.2%	9.16%	7.81%	100%	0.35

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	31.45B	49.6B	53.08B	14.55B	61.14B	40.65B	46.5B	-21.64B	12.98B	19.52B
Revenue Growth %	-0.28%	0.58%	0.07%	-0.73%	3.2%	-0.34%	0.14%	-1.47%	1.6%	0.5%
Medical Costs & Claims+	2.63B	3.4B	3.29B	0	0	0	36.5B	-24.67B	17.69B	0
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	28.82B	46.21B	49.79B	14.55B	61.14B	40.65B	46.5B	14.29B	2.37B	19.52B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.29%	0.6%	0.08%	-0.71%	3.2%	-0.34%	0.14%	-0.69%	-0.83%	7.24%
Operating Expenses+	-29.34B	-45.41B	-46.63B	-13.29B	-59.81B	2.88B	4.89B	2.2B	2.76B	18.86B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	1.52B	273M	148M	1.02B	850M	722M	1.17B	169M	34M	-31M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	-515M	804M	3.16B	1.26B	1.33B	37.78B	43.7B	834M	12.37B	657M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.38%	2.56%	2.94%	-0.6%	0.05%	27.49%	0.16%	-0.98%	13.84%	-0.95%
EBITDA+	1B	1.08B	3.31B	2.27B	2.18B	38.5B	44.87B	1B	12.41B	626M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	412M	347M	435M	507M	513M	405M	246M	7M	7M	6M
Non-Operating Income	1.83B	584M	-2.97B	-1.25B	0	0	0	0	384M	-9M
Pretax Income+	-514M	805M	2.39B	751M	1.46B	-957M	1.16B	827M	-391M	660M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	-83M	219M	32M	40M	218M	-336M	95M	71M	-209M	-16M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	-432M	586M	2.36B	710M	1.24B	45M	1.98B	-570M	-179M	688M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-1.36%	2.36%	3.03%	-0.7%	0.75%	-0.96%	43%	-1.29%	0.69%	4.84%
EPS (Diluted)+	-0.16	0.22	1.08	0.27	0.60	-0.09	0.48	-0.30	-0.12	0.30
EPS Growth %	-1.33%	2.38%	3.91%	-0.75%	1.22%	-1.15%	6.33%	-1.63%	0.6%	3.5%
EPS (Basic)	-0.16	0.22	1.08	0.27	0.60	-0.09	0.48	-0.30	-0.12	0.37
Diluted Shares Outstanding	2.69B	2.62B	2.62B	2.61B	2.06B	2.06B	2.06B	2.02B	1.89B	2.01B

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	415.42B	425.94B	396.29B	392.63B	440.35B	443.81B	468.25B	401.79B	301.58B	327.39B
Asset Growth %	-0.02%	0.03%	-0.07%	-0.01%	0.12%	0.01%	0.06%	-0.14%	-0.25%	0.09%
Total Investment Assets+	373.4B	367.67B	336.22B	339.9B	239.88B	259.13B	263.61B	316.76B	186.91B	352.54B
Long-Term Investments	182.24B	173.91B	149.85B	138B	148.67B	158.5B	162.24B	255.85B	186.91B	297.83B
Short-Term Investments	116.32B	111.09B	90.51B	86.25B	91.21B	100.63B	101.37B	60.91B	0	54.72B
Total Current Assets+	130.64B	130.97B	109.37B	101.01B	110.12B	115.83B	113.88B	73.19B	7.64B	30.33B
Cash & Equivalents	9.13B	11.35B	10.77B	8.74B	12.25B	8.37B	6.89B	3.41B	4.07B	3.47B
Receivables	1000K	0	0	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	25.69B	0	18.79B	108.67B	0	-31.69B
Goodwill & Intangibles+	1.9B	1.82B	1.63B	1.73B	1.56B	1.39B	1.33B	1.24B	504M	575M
Goodwill	299M	294M	293M	385M	392M	376M	392M	316M	291M	345M
Intangible Assets	1.6B	1.53B	1.34B	1.34B	1.17B	1.01B	941M	924M	213M	230M
PP&E (Net)	575M	572M	530M	235M	255M	211M	199M	158M	150M	400M
Other Assets	-25M	-87M	-79M	-360M	-193M	-101M	-131M	-169.4B	77.17B	28.59B
Total Liabilities	389.17B	401.2B	371.9B	370.07B	415.91B	419.15B	441.88B	387.6B	292.03B	318.08B
Total Debt+	13.49B	14.08B	14.53B	13.66B	12.02B	11.07B	12.23B	6.67B	4.92B	5B
Net Debt	4.36B	2.73B	3.76B	4.92B	-234M	2.71B	5.34B	3.27B	843M	1.53B
Long-Term Debt	13.36B	14.08B	14.53B	13.58B	11.65B	10.73B	11.98B	6.46B	4.68B	4.74B
Short-Term Debt	125M	0	0	82M	58M	72M	0	0	32M	37M
Total Current Liabilities+	2.66B	5.34B	4.65B	2.95B	3.31B	2.82B	3.08B	2.17B	9.2B	7.32B
Accounts Payable	2.54B	4.21B	4.58B	2.87B	3.26B	2.75B	3.08B	1.14B	2.11B	1.32B
Deferred Revenue	0	0	0	12M	11M	10M	9M	9M	0	0
Other Current Liabilities	-2.93B	-7.64B	-51M	-3.45B	-3.52B	-4.18B	-2.71B	-2.23B	6.73B	5.63B
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Liabilities	-13.36B	-16.28B	-14.53B	-13.6B	0	0	0	364.24B	280.01B	313.33B
Total Equity+	26.25B	24.73B	24.39B	22.57B	24.44B	24.66B	26.37B	14.19B	9.43B	9.31B
Equity Growth %	-0.07%	-0.06%	-0.01%	-0.07%	0.08%	0.01%	0.07%	-0.46%	-0.34%	-0.01%
Shareholders Equity	26.24B	24.72B	24.37B	22.55B	24.42B	24.59B	26.18B	10.76B	7.55B	9.19B
Minority Interest	9M	16M	20M	22M	20M	75M	196M	176M	129M	126M
Retained Earnings	8.1B	7.61B	9.7B	9.99B	10.67B	10.33B	12.17B	7.77B	5.1B	4.35B
Common Stock	328M	20.91B	20.57B	321M	323M	320M	321M	319M	265M	241M
Accumulated OCI	6.22B	4.91B	2.86B	1.76B	3.93B	4.39B	6.93B	-3.52B	-4.4B	-3.83B
Return on Equity (ROE)	-0.02%	0.02%	0.1%	0.03%	0.05%	0%	0.08%	-0.03%	-0.02%	0.07%
Return on Assets (ROA)	-0%	0%	0.01%	0%	0%	0%	0%	-0%	-0%	0%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.51x	0.57x	0.60x	0.61x	0.49x	0.45x	0.46x	0.47x	0.52x	0.54x
Book Value per Share	9.78	9.43	9.32	8.66	11.89	11.98	12.82	7.01	4.98	4.63
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	914M	3.31B	554M	517M	7.3B	-2.85B	-1.8B	2.85B	864M	762M
Operating CF Growth %	-0.78%	2.62%	-0.83%	-0.07%	13.12%	-1.39%	0.37%	2.59%	-0.7%	-0.12%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	-514M	610M	2.53B	751M	1.46B	-364M	2.4B	-922M	-162M	660M
Depreciation & Amortization	1.52B	1.21B	781M	1.31B	1.19B	722M	1.17B	1.16B	34M	-31M
Stock-Based Compensation	17M	0	0	0	0	0	0	48M	54M	0
Deferred Taxes	0	0	0	0	0	0	0	-48M	0	0
Other Non-Cash Items	5.9B	-10.31B	-13.19B	18.86B	-24.57B	-22.96B	-12.73B	63.45B	-9.69B	-11.97B
Working Capital Changes	-6B	11.81B	10.43B	-20.41B	29.23B	19.75B	7.36B	-60.84B	10.63B	12.1B
Cash from Investing+	615M	-1.08B	-1.2B	-438M	-86M	-139M	-54M	616M	-2B	300M
Capital Expenditures	-142M	-88M	-101M	-123M	-148M	-120M	-112M	-98M	-116M	-51M
Acquisitions	673M	-990M	-1.1B	-428M	-132M	-166M	-38M	570M	-1.95B	7M
Purchase of Investments	0	-112M	-121M	-146M	-269M	-305M	-98M	-130M	0	0
Sale/Maturity of Investments	0	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	1000K
Other Investing	84M	3M	1M	113M	462M	298M	133M	89M	72M	305M
Cash from Financing+	-2.79B	-457M	519M	-2.4B	-3.73B	-778M	300M	-1.83B	-3.24B	-1.75B
Dividends Paid	-292M	-306M	-294M	-328M	-309M	-63M	-121M	-167M	-494M	-521M
Share Repurchases	-213M	-623M	-266M	-248M	-318M	-59M	-231M	-597M	-1.07B	-925M
Stock Issued	1M	0	2M	0	1M	0	0	0	0	0
Debt Issuance (Net)	-1000K	1000K	1000K	-1000K	-1000K	-1000K	1000K	-1000K	-1000K	-1000K
Other Financing	1M	-177M	0	-336M	1.79B	-115M	-203M	-75M	-76M	-63M
Net Change in Cash+	-1.06B	1.75B	-321M	-2.28B	3.52B	-3.89B	-1.48B	1.6B	-4.41B	-605M
Exchange Rate Effect	1000K	-1000K	-1000K	1000K	1000K	-1000K	1000K	1000K	-1000K	1000K
Cash at Beginning	10.65B	9.59B	11.35B	11.03B	8.74B	12.26B	8.37B	6.89B	8.49B	4.07B
Cash at End	9.59B	11.35B	11.03B	8.74B	12.26B	8.37B	6.89B	8.49B	4.07B	3.47B
Free Cash Flow+	772M	3.22B	453M	394M	7.15B	-2.97B	-1.91B	2.75B	799M	711M
FCF Growth %	-0.81%	3.17%	-0.86%	-0.13%	17.16%	-1.42%	0.36%	2.44%	-0.71%	-0.11%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	0.29	1.23	0.17	0.15	3.48	-1.45	-0.93	1.36	0.42	0.35

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	-84.94%	-84.69%	-81.65%	-91.36%	-97.83%	7.08%	88.99%	103.83%	157.54%	96.63%
Medical Cost Ratio	8.35%	6.84%	6.2%	0%	0%	0%	78.49%	113.98%	136.28%	0%
Return on Equity (ROE)	-1.59%	2.3%	9.61%	3.02%	5.27%	0.18%	7.76%	-2.81%	-1.52%	7.34%
Return on Assets (ROA)	-0.1%	0.14%	0.57%	0.18%	0.3%	0.01%	0.43%	-0.13%	-0.05%	0.22%
Equity / Assets	6.32%	5.81%	6.15%	5.75%	5.55%	5.56%	5.63%	3.53%	3.13%	2.84%
Book Value / Share	9.78	9.43	9.32	8.66	11.89	11.98	12.82	7.01	4.98	4.63
Debt / Equity	0.51x	0.57x	0.60x	0.61x	0.49x	0.45x	0.46x	0.47x	0.52x	0.54x
Revenue Growth	-28.42%	57.75%	7.01%	-72.59%	320.15%	-33.5%	14.39%	-146.54%	159.96%	50.4%

Revenue by Geography

	2017	2018	2019	2020	2021	2022	2023	2024
Americas	9.38B	370.58B	411.59B	-	450B	392.94B	386.81B	402.12B
Americas Growth	-	3849.52%	11.07%	-	-	-12.68%	-1.56%	3.96%
NETHERLANDS	2.21B	-	92.4B	-	103.88B	10.95B	-	-
NETHERLANDS Growth	-	-	-	-	-	-89.46%	-	-
International	-	-	-	919M	-	-	-	-
International Growth	-	-	-	-	-	-	-	-
Southern And Eastern Europe	-	-	8.89B	-	-	-	-	-
Southern And Eastern Europe Growth	-	-	-	-	-	-	-	-
Asia	816M	-	8.21B	-	-	-	-	-
Asia Growth	-	-	-	-	-	-	-	-
Central and eastern europe	628M	-	-	-	-	-	-	-
Central and eastern europe Growth	-	-	-	-	-	-	-	-
Spain and portugal	155M	-	-	-	-	-	-	-
Spain and portugal Growth	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Aegon Ltd. (AEG) has a price-to-earnings (P/E) ratio of 25.6x. This suggests investors expect higher future growth.

Growth & Financials

Aegon Ltd. (AEG) grew revenue by 50.4% over the past year. This is strong growth.

Yes, Aegon Ltd. (AEG) is profitable, generating $1.25B in net income for fiscal year 2024 (3.5% net margin).

Dividend & Returns

Yes, Aegon Ltd. (AEG) pays a dividend with a yield of 3.38%. This makes it attractive for income-focused investors.

Aegon Ltd. (AEG) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.

Industry Metrics

Aegon Ltd. (AEG) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...